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Abstract Inositol Inpp5k (or Pps, SKIP) is a member of
the inositol polyphosphate 5-phosphatases family with a
poorly characterized function in vivo. In this study, we
explored the function of this inositol 5-phosphatase in mice
and cells overexpressing the 42-kDa mouse Inpp5k protein.
Inpp5k transgenic mice present defects in water metabolism
characterized by a reduced plasma osmolality at baseline, a
delayed urinary water excretion following a water load, and
an increased acute response to vasopressin. These defects
are associated with the expression of the Inpp5k transgene
in renal collecting ducts and with alterations in the arginine
vasopressin/aquaporin-2 signalling pathway in this tubular
segment. Analysis in a mouse collecting duct mCCD cell
line revealed that Inpp5k overexpression leads to increased
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expression of the arginine vasopressin receptor type 2 and
increased cAMP response to arginine vasopressin, provid-
ing a basis for increased aquaporin-2 expression and plasma
membrane localization with increased osmotically induced
water transport. Altogether, our results indicate that Inpp5k
5-phosphatase is important for the control of the arginine
vasopressin/aquaporin-2 signalling pathway and water
transport in kidney collecting ducts.
Keywords Water transport . Aquaporin . Phosphoinositide
metabolism . 5-Phosphatase . Collecting duct
Introduction
Phosphatidylinositol (4,5)-bisphosphate (PtdIns(4,5)P2)
and phosphatidylinositol (3,4,5)-trisphosphate (PtdIns
(3,4,5)P3) demonstrate second messenger functions in
multiple biological processes. PtdIns(4,5)P2 controls,
among others, the dynamic turnover of actin cytoskeleton,
assembly/disassembly of vesicular coats, secretion, gene
expression and the fate of endocytic vesicles [13, 17, 29,
40]. It also regulates the activity of many ion channels and
transporters [35, 36]. PtdIns(4,5)P2 is mainly localized in
the inner leaflet of plasma membranes, but smaller pools
have been detected in intracellular membranes, including
Golgi, endoplasmic reticulum, endosomes and lamellipodia
[13]. Mechanistically, a very large number of proteins are
recruited to PtdIns(4,5)P2 via pleckstrin homology (PH),
phagocyte oxidase (PX), Fab1p, YOTB, Vac1p and EEA1
(FYVE), epsin N-terminal homology (ENTH) domains or
through small patches of basic amino acids [13, 18, 28].
PtdIns(4,5,)P2 also serves as precursor of five essential
signalling molecules: diacylglycerol, inositol (1,4,5)-
trisphosphate, PtdIns4P, PtdIns5P and PtdIns(3,4,5)P3 [13,
17]. In non-stimulated cells, PtdIns(3,4,5)P3 levels are very
low in the plasma membrane, reaching ~0.1% of the level
of PtdIns(4,5)P2 [13, 17]. Upon cell activation, PtdIns
(3,4,5)P3 levels are transiently increased by a factor ranging
from 2- to 100-fold. This phosphoinositide is implicated in
the control of cell survival, growth and proliferation,
resistance to apoptosis, regulation of cytoskeleton dynam-
ics, membrane trafficking, cell migration, and many of the
metabolic responses to insulin [12, 13]. PtdIns(3,4,5)P3
regulates a wide variety of effector proteins primarily by
binding and recruiting specific proteins.
In mammalian cells, PtdIns(4,5)P2 and/or PtdIns(3,4,5)
P3 are substrates for several members of the phosphoinosi-
tide 5-phosphatases family, including Inppl1 (or SHIP2),
Inpp5e and Inpp5k (or SKIP, for skeletal muscle and kidney
enriched inositol phosphatase, and Pps, for putative
phosphatase) [2, 7, 30, 32, 33]. These enzymes tightly
control the level of the above-mentioned phosphoinositides
in a tissue-, cellular-, subcellular- and signalling cascade-
specific way. Importantly, inactivation or overexpression of
most members of this family has been associated with
diseases in mouse and man [3, 30, 32, 33]. For example,
Inpp5e is localized in the primary cilium of differentiated/
quiescent cells; mice and man with genetic alterations in the
Inpp5e gene develop ciliopathies [6, 22]. SHIP2 knock-out
mice are resistant to high fat diet-induced obesity and have
glucose metabolism alterations [10, 34]; polymorphisms in
the SHIP2 gene have been identified in cohorts of type 2
diabetic patients, and overexpression of SHIP2 in transgen-
ic mice is associated with glucose metabolism and insulin
sensitivity defects [25, 26, 31].
Inpp5k is a PtdIns(4,5)P2 and PtdIns(3,4,5)P3 5-
phosphatase. It is highly expressed in human skeletal
muscles and kidney, hence its previous name SKIP [19].
In N1E-115 neuroblastoma cells, human Inpp5k regulates
the actin cytoskeleton [19]. Human Inpp5k is translocated
from the endoplasmic reticulum to plasma membrane
ruffles following activation by EGF and insulin in Cos-7
and skeletal muscle C2C12 cell lines, respectively [16, 39].
Activation of PKB and p70 S6 kinases as well as GLUT4
glucose transporter translocation to the plasma membrane
and membrane ruffles formation were significantly de-
creased in human Inpp5k-transfected and insulin-stimulated
CHO cells [20]. Mice totally deficient for Inpp5k die during
embryonic life for still unknown reason; Inpp5k+/− mice
have increased insulin sensitivity in skeletal muscles,
confirming the results obtained in different cell lines [21].
However, the role of Inpp5k in the kidney, another tissue
where the phosphatase has been reported to be highly
expressed, and its potential implication in a metabolic or a
pathologic process in this tissue remain undefined.
In order to explore the function of Inpp5k in vivo,
we generated and characterized a transgenic mouse line
expressing the mouse Inpp5k 5-phosphatase in many
tissues. Our in vivo and in vitro results reveal that
overexpression of Inpp5k in kidney collecting duct cells
is associated with defects in water handling paralleled
by alterations in the arginine vasopressin (AVP)/
aquaporin-2 (AQP2) signalling pathway resulting in
impaired osmoregulation.
Materials and methods
RNA analysis in mouse tissues and cells
For Northern blot analysis, total RNA was extracted from
mouse tissues using the TriPure Isolation reagent (Roche
Applied Sciences) and loaded (10 μg/lane) on agarose gel.
A 944-bp DNA fragment of the mouse Inpp5k cDNA
served as a radiolabelled probe. A radiolabelled probe
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consisting of a 600-bp DNA fragment of the mouse
hypoxanthine–guanine phosphoribosyltransferase (HPRT)
cDNA served as loading control.
For reverse transcription-polymerase chain reaction (RT-
PCR) analysis on FACS-purified populations of dendritic
cells, mast cells, macrophages, neutrophils, eosinophils, T
and B lymphocytes, RNA was extracted and reverse-
transcribed using random hexamers. cDNA was amplified
by PCR using forward and reverse primers located in exon
8 and exon 12 of the mouse Inpp5k gene, respectively (see
Table S1 for the primers sequence; annealing temperature,
55.5°C; 30 cycles). For RT-PCR and real-time RT-PCR
analysis on 6-month-old mouse kidney and brain and on
mCCD cells, total RNA and cDNA were obtained as
described [24]. The primers (Table S1) were designed using
Primer3. Changes in target gene mRNA levels were
determined in duplicate by relative RT-qPCR with a
CFX96™ Real-Time PCR Detection System (Bio-Rad
Laboratories, Hercules, CA) using iQ™ SYBR Green
Supermix (Bio-Rad) detection of single PCR product
accumulation. The PCR conditions, the negative controls,
the preparation of the standard curves and the calculation of
the reaction efficiencies were as previously described [1].
Antibodies
An affinity-purified rabbit antibody against the
RSFLREDTLYEPEPQI carboxy-terminal mouse Inpp5k
peptide was obtained from Eurogentec, Liège, Belgium.
Pre-incubation of the anti-Inpp5k antibody with the
immunogenic peptide resulted in the disappearance of the
signal in Western blot, immunoprecipitation and immuno-
histochemistry analyses (data not shown). Rabbit polyclon-
al antibodies raised against the AQP2 (Sigma-Aldrich),
phosphorylated Ser256 AQP2 (p-AQP2) [8] and NKCC2
(Millipore), sheep anti-megalin (a gift from P. Verroust,
Paris, France) [9], mouse monoclonal antibodies against the
M2 clone of Flag® tag (FITC-conjugated, Sigma-Aldrich)
and β-actin (Sigma-Aldrich), and Alexa633-labelled sec-
ondary anti-IgG antibodies (Invitrogen, Belgium) were also
used.
Protein analysis
Tissues were homogenized in a buffer containing NP-40
(1%), Tris–HCl pH 8 (50 mM), NaCl (150 mM), and
protease inhibitors (Complete™, Roche Diagnostics
GmbH). Cell lysates were obtained by solubilizing frozen
pellets in lysis buffer containing Complete Mini (Roche),
followed by sonication and centrifugation at 16,000×g for
1 min at 4°C. When needed, total membrane and cytosolic
fractions were separated by centrifugation (100,000×g for
2 h). Protein concentrations were determined using BCA
protein assay (Pierce, Aalst, Belgium). Cell and tissue
samples were normalized for protein levels, diluted in
Laemmli sample buffer, separated by SDS-PAGE in
reducing conditions, and blotted onto nitrocellulose or
PVDF membranes. After blocking with non-fat milk,
membranes were incubated overnight at 4°C with the
primary antibody, washed, incubated with peroxidase-
labelled secondary antibody, and visualized with enhanced
chemiluminescence (Perkin Elmer).
When indicated, protein analysis was performed after
immunoprecipitation of the Inpp5k protein either with the
anti-Flag or the anti-Inpp5k rabbit polyclonal antibodies
and protein A Sepharose CL-4B (Amersham). In these
conditions, an HRP-coupled anti-Flag monoclonal antibody
and a biotin-coupled anti-Inpp5k polyclonal antibody were
used as primary antibodies in the Western blotting. For
surface biotinylation assay, 10-day-old confluent mono-
layers of mCCD cells were incubated with Sulfo-NHS-
biotine (1.5 mg/ml; Pierce) at 4°C. Excess biotine was
quenched by incubation with 100 mM glycine and cells
were lysed in Ripa buffer containing protease inhibitors.
Lysate was centrifuged, and its supernatant was incubated
with streptavidine-conjugated agarose droplets (Pierce) to
purify apical membranes from the cytosolic fraction.
Proteins were extracted from renal cortex and medulla
samples as described [24].
Malachite phosphatase assay
Inpp5k protein was immunoprecipitated from kidney
extracts as described above. Inpp5k phosphoinositide
phosphatase activity was measured with a phosphate release
assay using an acidic malachite green. Briefly, Inpp5k
protein immunoprecipitates were incubated with 100 μM of
either PtdIns(3,4,5)P3 di-C16 or PtdIns(4,5)P2 di-C16 in
mixed vesicles of Ptdserine for 10 min at 37°C. Reactions
were stopped by addition of EDTA. After centrifugation,
supernatants were incubated with malachite green reagent
for 10 min. Absorbance was measured at 650 nm. As
negative controls, we used the anti-Inpp5k antibody pre-
incubated with the immunogenic peptide before adding the
protein extract, and the anti-Flag antibody without addition
of any kidney extract. Inorganic phosphate release was
quantified by comparison to a standard curve of KH2PO4 in
dH2O.
Lentivirus construction and production
pWPXLd, psPAX2 and pMD2.G plasmids were obtained
from D. Trono (Ecole Polytechnique Fédérale de Lausanne,
Lausanne, Switzerland). The chicken β actin promoter/
enhancer, the cytomegalovirus immediate-early enhancer
(altogether referred as the CAGG promoter), a β globin
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intron, the eGFP cDNA flanked by loxP sites and the
octapeptide Flag amino-terminal-tagged mouse Inpp5k
cDNA corresponding to the 42-kDa isoform of the Inpp5k
protein (NM-008916) were introduced between the two
LTR sequences in the pWPXLd plasmid. This plasmid was
named pWPXLd/GFP/Inpp5k. A pWPXLd/Inpp5k plasmid
was obtained after transformation of 294 Cre-expressing
bacteria with the pWPXLd/GFP/Inpp5k plasmid. Recom-
binant lentiviruses were obtained after transfection of 293 T
cells with the pWPXLd/GFP/Inpp5k, psPAX2 and pMD2.G
plasmids. After 2 days, the lentivirus-containing superna-
tant was harvested, purified and concentrated by ultracen-
trifugation, and resuspended in KSOM embryo culture
medium (Specialty Media). The concentrated lentiviral
suspension was titrated by infection of 293T cells for 2 days
followed by GFP expression analysis using a flow
cytometer.
Production of lentigenic mice
Two to four cell embryos were recovered from super-
ovulated (C57BL/6 × Balb/c)F1 female mice crossed with
F1 males. Embryos were depellucided with tyrode acid
(Sigma) and incubated with 5–10×103 lentiviral particles in
a drop of KSOM medium under mineral oil (Sigma). After
2 days at 37°C and 5% CO2, viable embryos were rinsed
several times with M2 embryo culture medium (Sigma) and
reimplanted in the uterine horns of pseudogestant CD1
females (Harlan). Newborns were screened for GFP
expression in the tail by fluorescent microscopy (Nikon
Eclipse TE300). GFP/Inpp5k transgenic founders were
crossed with PGK-Cre mice in order to remove the GFP
cDNA from the inserted transgene and to obtain Inpp5k
transgenic mice. GFP/Inpp5k and Inpp5k transgenic mice
were backcrossed with C57BL/6 mice for five generations
before analysis. No Cre transgene was left in the experi-
mental mice. Non-transgenic littermates resulting from the
crossing between Inpp5k transgenic mice and C57BL/6
mice, as well as age-matched GFP/Inpp5k transgenic mice
served as controls. All animal studies were authorized by
the Animal Care Use and Review Committee of the
Université Libre de Bruxelles.
DNA analysis
Genomic DNAwas extracted from tail tips and analyzed by
Southern blotting and PCR. DNA was digested with EcoRI
or SpeI, loaded on an agarose gel and transferred onto a
nitrocellulose membrane. A 950-bp DNA fragment of the
mouse Inpp5k cDNAwas used as a radiolabelled probe. For
genotyping, PCR was used to amplify a DNA fragment of
eGFP or Inpp5k cDNAs present in the transgene (see Table
S1 for primer sequences).
Renal salt and water handling protocols
Experiments were conducted on age- and gender-matched
mice. Water handling at baseline and during various
protocols was assessed in individual metabolic cages, after
appropriate training, as described [1, 5]. Plasma samples
and 24-h urine collections were obtained at baseline, and
urinary concentrating ability was tested after 24-h water
deprivation. The capacity to excrete a water load was tested
after i.p. injection of 2 ml of sterile water; urine was
collected under a plastic-wrapped container on an hourly
basis for the next 6 h as described [1]. The acute response
to vasopressin was investigated by treating mice with an i.
p. injection of 1 ng/g body weight of dDAVP (desmopres-
sin) (Minirin®, Ferring, Switzeland) in 100 μl of saline i.p.
and collection of urine 5 h later to measure osmolality.
Plasma and urine analyses
Plasma urea, glucose and creatinine were measured after
appropriate sample dilution with a Synchron CX5 Analyzer
(Beckman Coulter), and osmolality was measured using a
Fiske Osmometer (NeedhamHeights,MA), as described [1, 5].
Histology and immunohistochemistry
Kidney samples were fixed in 4% paraformaldehyde
(Boehringer Ingelheim, Heidelberg, Germany) in 0.1%
mol/l phosphate buffer (pH 7.4) before embedding in
paraffin, and processed for staining and antibodies incuba-
tion as described [1]. Sections were viewed under a Zeiss
LSM510Meta Confocal microscope (Zeiss, Belgium).
Fluorescence measurements were performed with a x63/
1.4 Plan-Apochromat oil-immersion objective (Zeiss).
mCCD cell culture, transfection, immunostaining, response
to vasopressin and fluid transport measurement
mCCD cells were cultured on collagen-coated PTFE filter
membranes as described [14]. At 60–80% confluency, mCCD
cells were transfected or not with a pWPXLd plasmid
expressing either the wild-type or the catalytically inactive
Inpp5k protein by the use of Fugene HD (Roche). The
catalytically inactive 42-kDa mouse Inpp5k protein was
obtained after mutation of the wild type Inpp5k cDNA,
according to Communi et al. [11] and Wada et al. [38]: the
P283, D287 and R288 of the catalytic domain of the Inpp5k
protein were respectively mutated in A, A and G. Six- to ten-
day-old confluent monolayer cells were used in the experi-
ments. For immunostaining, cells were fixed, permeabilized
and incubated with a goat anti-rabbit AQP2 and a monoclonal
anti-Flag® antibodies coupled with Alexa633 and FITC,
respectively. Nuclei were stained with DAPI. Cells were
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analyzed with a Zeiss LSM510Meta Confocal microscope
(Zeiss, Belgium). The response to vasopressin was tested by
treating the filter-seeded cells (transfected or not, as described
above) with 10 nM dDAVP (Sigma) for 5 min in the presence
of 1 mM 3-isobutyl-1-methylxanthine (IBMX, Sigma). After
treatment, cells were washed, incubated with sample diluent
for 10 min at room temperature and centrifuged at 600×g at
4°C for 15 min. Fifty μl of the supernatant were used to assay
cAMP, using a direct cAMP enzyme immunoassay kit (Arbor
Assays, Ann Arbor, MI, USA) according to the Manufac-
turer’s instructions. Data are based on three independent
experiments performed in duplicate.
Cellular fluid transport
Fluid transport was determined in confluent monolayers of
mCCD cells at day 10 as described previously [15]. For
baseline volume measurement, cell culture medium was
changed and replaced with fixed volume of media
introduced in apical and basolateral sides. After an
incubation time of 2 or 15 h, the apical and basolateral
medium were collected and measured on a precision
balance. For the effect of an osmotic gradient on fluid
transport, a fixed volume of diluted culture medium (2/5)
was added to the apical side, while undiluted (5/5) culture
medium was added to the basolateral side. After 2 h, both
apical and basolateral volumes were collected and mea-
sured. HgCl2 (1 mM), the aquaporins inhibitor, was added
to the apical side in the presence of a concentration gradient
(2/5 apical and 5/5 basolateral). After 2 h, apical and
basolateral volumes were collected and measured. Protein
levels from each cell culture were determined with a BCA
kit (Pierce), and were found to be similar in all conditions.
Nephron segments microdissection
Eight-week-old C57Bl/6 mice were used for microdissec-
tion of individual nephron segments. Briefly, thin coronal
kidney slices were prepared, after which cortex and medulla
were separated and digested with collagenase type II (1 mg/
ml) for 30 min (for proximal tubules) or 1 h (for other
tubules) at 37°C. Then, tubule suspension was washed and
placed on a stage of an inverted microscope. A total of 50
proximal tubules (S1S2 and S3), thick ascending limbs of
Henle’s loop (TAL), and collecting ducts (CD) were
collected and placed in 300 μl RLT buffer (Qiagen). Total
RNAwas extracted immediately after microdissection using
the RNAeasy Micro kit (Qiagen).
Statistics
All values are expressed as means ± standard error of the
mean (SEM). Significance of differences between two
means was calculated using the GraphPad InStat software
(GraphPad Software, San Diego, CA, USA). The signifi-
cance level of the differences of the means (P value) is
indicated in the legend of each figure.
Results
Production and characterization of Inpp5k transgenic mice
In order to study the role of mouse Inpp5k phosphatase
in vivo, a transgenic mouse expressing a Flag-tagged
42-kDa Inpp5k protein was generated by infection of
embryos with a recombinant lentivirus. Since our
preliminary results indicated that Inpp5k expression is
ubiquitous in mouse (Suppl. information and Fig. S1), a
transgene was constructed containing the chicken β
actin promoter/enhancer and the cytomegalovirus
immediate-early enhancer (altogether referred as the
CAGG promoter) which are known to direct expression
of the transgene in many tissues in genetically modified
mouse (Fig. 1). Downstream of the CAGG promoter, the
transgene contained a β globin intron, the GFP cDNA
flanked by loxP sites, and the octapeptide Flag-tagged
mouse Inpp5k cDNA. The transgene was inserted into
the pWPXLd lentiviral plasmid and successfully tested
for mutually exclusive expression of GFP or Inpp5k
proteins in 293 cells (Suppl. information and Fig. S2).
Mouse embryos were infected with lentiviral particles
and reimplanted in pseudogestant females. The presence
of founders in the progeny was checked at birth by tail
fluorescence analysis and confirmed by PCR analysis.
Out of 21 newborns, two were fluorescent and both
transmitted the transgene to their progeny (data not
shown). Experiments were done to demonstrate that
both lentiviral transgenic lines A and B had sole
transgene integration in the genome, produced the
Inpp5k transgene only after Cre recombination, and that
the transgenic Inpp5k protein was ubiquitously
expressed and catalytically active in both lines (Suppl.
information, Fig. S3 and data not shown). We also
confirmed that both PtdIns(4,5)P2 and PtdIns(3,4,5)P3
are substrates for the murine Inpp5k protein (Suppl.
information and Fig. S3). Given the higher amount of
Inpp5k protein and 5-phosphatase activity detected in
tissues of transgenic line B, this line was used in the
following experiments. Age-matched non-transgenic lit-
termates and transgenic line B mice expressing the GFP
protein served as controls. As no significant difference
was observed between both groups of control mice, a
potential effect of the transgene integration site on the
observed phenotype was discarded, and these two
groups were finally pooled.
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Altered osmoregulation in Inpp5k transgenic mice
Inpp5k transgenic mice were fertile and had a normal life
span and general behaviour. No evident macroscopic nor
microscopic alterations were detected in all tissues exam-
ined (data not shown). As Inpp5k mRNA and protein have
been reported to be highly expressed in the kidney [19],
renal function and osmoregulation parameters at baseline
were investigated. Control and Inpp5k transgenic mice
were similar in terms of body weight, water intake, urinary
flow rate and renal function (plasma urea and creatinine)
(Table S2). However, transgenic Inpp5k mice had a
significantly lower plasma osmolality than control mice
(350±3.7 and 335±4.3 mOsm/kg H2O in control and
transgenic mice, respectively; P<0.03, 5–6 mice per
group). These data suggested an abnormal osmoregulation
in Inpp5k transgenic mice and led us to analyze the renal
expression of endogenous and transgenic Inpp5k as well as
water handling by the kidney in these mice.
Inpp5k expression in control and Inpp5k transgenic mice
Endogenous Inpp5k mRNA expression was investigated by
RT-PCR in the different nephron segments of wild-type
kidneys: endogenous Inpp5k mRNA was found in all
segments, with the highest expression in the proximal
tubule segments (Fig. 2a and b). The presence of the 44-
kDa Flag-tagged Inpp5k transgenic protein was identified
in both cortical and medullary fractions of Inpp5k trans-
genic kidneys (Fig. 2c). As expected, total Inpp5k protein
expression was increased in transgenic kidneys, as com-
pared to control kidneys. Kidney sections from control and
Inpp5k transgenic mice were stained for total and trans-
genic Inpp5k proteins with an anti-Inpp5k and an anti-Flag
antibody, respectively, and analyzed at the confocal
microscope (Fig. 3a). The Flag-tagged transgenic Inpp5k
protein was detected in the proximal tubules and the
medullary collecting ducts of transgenic kidneys, but not
in control kidneys, as expected. As compared with
endogenous Inpp5k expression in control kidneys, total
Inpp5k protein expression was increased in transgenic
kidneys. Cellular co-localization of the Flag-tagged Inpp5k
transgenic protein with megalin (a proximal tubule marker)
and AQP2 (a collecting duct marker) confirmed the
expression of the transgenic Inpp5k protein in these specific
nephron segments (Fig. 3b). Interestingly, the expression of
AQP2 was distinctly upregulated in the medullary collect-
ing ducts of Inpp5k transgenic kidneys, whereas megalin
and NKCC2 (a thick ascending limb of Henle’s loop
marker) were found unchanged, as compared with control
kidneys (Fig. 3b and data not shown).
Abnormal water handling in Inpp5k transgenic mice
The altered plasma osmolality associated with the expres-
sion of the transgenic Inpp5k protein in specific nephron
segments known to control water and/or ions transport
suggested abnormal osmoregulation in Inpp5k transgenic
mice. In order to substantiate this defect, we first tested the
urinary concentrating ability of Inpp5k transgenic mice
following a water deprivation test. The water deprivation
resulted in a similar weight loss in control and Inpp5k
transgenic mice (averaging 14±0.4% in control mice and
13±0.8% in Inpp5k transgenic mice, n=5 pairs) and, as
expected, a significant reduction in the urine volume (Fig.
S5). These changes were similar in both groups of mice,
indicating that the mechanisms of solute accumulation in
the medulla (i.e., transport of Na+ and urea) allowing a
maximal urinary concentration were not affected by Inpp5k
overexpression. The latter hypothesis was also supported by
the similar response of the control and Inpp5k transgenic
mice to the loop diuretic furosemide (data not shown).
We next evaluated the capacity of the transgenic kidney
to eliminate a water load by diluting urine (Fig. 4a). As
compared with control mice, Inpp5k transgenic mice
showed a significant delay in their ability to excrete the
water load, pointing to a defective handling of water in the
collecting duct. The acute response to vasopressin was also
CAGG LTRintron Inpp5kLTR GFP
LoxP LoxP
Flag
CAGG LTRintron Inpp5kLTR
LoxP
Flag
a
b
Fig. 1 Inpp5k transgene structure. Transgene structure before (a) and
after (b) Cre recombination showing the CAGG promoter (including
the CMVenhancer), the β globin intron, a first loxP site, the enhanced
green fluorescent protein (GFP) cDNA, a second loxP site, and the
Flag-tagged mouse Inpp5k cDNA. A viral LTR is present at both
transgene extremities
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investigated in these mice, revealing that the maximal urine
osmolality was significantly higher in Inpp5k transgenic
mice as compared with controls (3,815±100 vs. 2,561±
254 mOsm/kg H2O, P<0.005; Fig. 4b). Together, the lower
plasma osmolality, impaired ability to excrete a water load
and increased response to dDAVP indicated that Inpp5k
transgenic mice had a significant defect in osmoregulation,
which could be related to a specific effect of Inpp5k on the
vasopressin/AQP2 axis in the kidneys.
Abnormal arginine vasopressin signalling pathway
in Inpp5k transgenic mice
In order to investigate the mechanism of altered water
handling in Inpp5k transgenic mice, real time RT-PCR was
first used to test for the differential expression of transcripts
that are primarily involved in the AVP signalling pathway,
including AVPR2 receptor and AQP2 in the kidney, and
AVP in the brain (Fig. 4c). The expression of AVPR2 and
AQP2 mRNAwere significantly increased in the kidneys of
the Inpp5k transgenic mice as compared with controls. By
contrast, the kidney expression of transcripts corresponding
to pathways involved in Na+ or K+ handling (e.g., Na+/K+-
ATPase and the different ENaC subunits) was unchanged
(Fig. 4b). In the brain, AVP mRNA expression was found
significantly decreased in Inpp5k transgenic mice, as
expected from a feedback response of the lower plasma
osmolality values (Fig. 4c). We next investigated AQP2
protein expression and phosphorylation in transgenic
kidneys by Western blotting (Fig. 4d and e). Immunoblot
analyses essentially confirmed the immunostaining results
presented in Fig. 3b: a significant overexpression of AQP2
protein was detected in the transgenic kidney as compared
with control kidney. The proportion of phosphorylated
AQP2 protein was also significantly increased in Inpp5k
transgenic kidney (Fig. 4e).
Together, these results indicate that the osmoregulation
defect detected in Inpp5k transgenic mice is caused by
alteration in the AVPR2/AQP2 signalling pathway in
kidney collecting ducts.
AQP2 and AVPR2 expression, cAMP production and water
transport in mouse collecting duct cells overexpressing
Inpp5k
The mouse CCD (mCCD) cells represent a well established
model to investigate the mechanisms of water reabsorption
in the collecting duct. In order to confirm and substantiate
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Inpp5k transgenic (Tg) mice. Cytosolic proteins (20 μg) were
separated by SDS-PAGE and blotted onto nitrocellulose membrane,
before incubation with anti-Inpp5k (1/1,000) or anti-Flag (1/1,000)
affinity-purified antibodies. Loading control was performed after
membrane stripping and incubation with monoclonal anti-β-actin
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the link between Inpp5k overexpression and the water
handling defect observed in mice, mCCDcells were plated
on filters and transfected or not with either a catalytically
active or inactive Inpp5k expression vector. The cells were
then cultured to confluency to develop a polarized
monolayer. Transfection of mCCD cells with wild type
Inpp5k resulted in higher AQP2 protein expression and
plasma membrane localization than in non-transfected cells
(Fig. 5a–c). An intact Inpp5k enzymatic activity was
required to observe the AQP2 expression and localization
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Fig. 4 Abnormal water handling, acute response to vasopressin
and renal AQP2 expression in Inpp5k transgenic mice: a The
urine output was analyzed in control (white bars) and Inpp5k
transgenic (black bars) mice during 4 h in a test of acute water
loading (2 ml intraperitoneally). Results are means±SEM of six
pairs of 5-month-old male mice and are expressed as milliliter of
urine excreted over the last 1-h interval. *P<0.05. b Effect of
dDAVP treatment on urine osmolality in control and Inpp5k
transgenic mice. After adaptation and baseline collection, mice were
treated with 1 ng/g body weight of dDAVP (Minirin®) and urine was
collected 5 h later to measure osmolality (Uosmo). The two groups
of mice show similar urine osmolality values at baseline, whereas
treatment with dDAVP induces a significantly higher response in the
Inpp5k transgenic mice vs. controls. Data were obtained on four
pairs of control vs. transgenic Inpp5k mice. **P<0.005. c Real-time
RT-PCR quantification of mRNA expression in the kidney and the
brain. Messenger RNA levels were first adjusted to glyceraldehydes-
3-phosphate deshydrogenase (GAPDH), then normalized to the
control mice level set at 100% using the following formula:
Ratio ¼ 2ΔCt GAPDHtargetInpp5ktransgenicmiceð ÞΔCtðGAPDHtargetcontrolmiceÞ.
The normalized values (mean±SEM) are shown on the right-hand
side of the panel. Eight pairs of kidney and brain from 5-month-old
male mice were analyzed. *P<0.05. d Western blot analysis of
AQP2, phosphorylated AQP2 (p-AQP2) and actin (as a loading
control) in kidney extracts from control (C) and Inpp5k transgenic
mice (Inpp5k). Five pairs of kidney from 5-month-old male mice
were analyzed. e Densitometry analyses (core and glycosylated
bands) confirm that there is a significant increase of both AQP2 and
p-AQP2 proteins in the kidney extracts from Inpp5k transgenic
(black bars) mice, as compared with control (white bars) mice.
Results are means±SEM and are expressed as a ratio between AQP2
or p-AQP2 signals and actin signal. *P<0.05, **P<0.005
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defects, since transfection of mCCD cells with a catalyti-
cally inactive Inpp5k protein had no effect (Fig. 5). Further
studies demonstrated that cells transfected with wild-
type Inpp5k had a significantly higher mRNA expres-
sion of AVPR2 (Fig. 5d), which was reflected by a
significantly (>2-fold) accentuated cAMP response to
treatment with dDAVP (Fig. 5e). Again, these changes
were not observed in cells transfected with the catalyti-
cally inactive Inpp5k.
These AQP2 and AVPR2 studies were correlated with
measurement of net water transport across polarized mCCD
cell monolayers (Fig. 6). Indeed, 2 and 15 h after placing
iso-osmotic media on both sides of the mCCD cell
monolayer, an increased water transport was detected in
wild-type Inpp5k-transfected cells, as compared with non-
transfected and catalytically inactive Inpp5k transfected
cells. When a hypo-osmotic medium was placed at the
apical side of the mCCD cell monolayer, water transport
was increased in all three conditions tested. However, water
transport was still significantly increased in wild type
Inpp5k transfected cells (Fig. 6). Addition of HgCl2, which
blocks AQP2 by interacting with a critical cysteine residue
in the water pore, nearly completely blocked the osmoti-
cally induced water transport in all cells tested (Fig. 6).
Together, these results indicate that the active form of
Inpp5k tightly controls AQP2 expression and plasma
membrane localization, as well as the osmotically induced
water transport in mouse collecting duct cells.
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cAMP production in Inpp5k-transfected mCCD cells: a Non-
transfected, wild-type or catalytically inactive Inpp5k-transfected
mCCD cells were cultured to confluency on filters to obtain a
polarized cell monolayer. Anti-AQP2 (red) and anti-Inpp5k (green)
antibodies were incubated with permeabilized cells and analyzed by
confocal microscopy. b Western blot analysis of non-transfected and
wild type or catalytically inactive Inpp5k-transfected mCCD cell
protein extracts with an anti-AQP2 antibody. Actin served as loading
control. c Plasma membrane of 10-day-old confluent mCCD cells
under control conditions (c) or after transfection with either wild type
Inpp5k (In) or catalytically inactive Inpp5k (inIn) were obtained after
biotinylation assay. Plasma membrane and cytosol fraction were
analysed by Western blotting with an anti-AQP2 antibody. Equal
amounts of protein (20 μg/lane) were charged. d Increased expression
of Avpr2 in Inpp5k-transfected mCCD cells. Quantification (real-time
PCR) of target mRNA in mCCD, expressed as relative expression
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(10 nM) on cAMP production in mCCD cells transfected with Mock
or inactive Inpp5k or Inpp5k plasmid. mCCD grown on filter
membranes were pretreated with 1 mM 3-isobutyl-1-methylxanthine
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condition). Significant differences (*P<0.05, **P<0.01, ***P<0.001)
between different conditions are indicated. Data are mean±SEM
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Discussion
We report here that transgenic mice overexpressing the
phosphoinositide 5-phosphatase Inpp5k present an altered
water metabolism characterized by a decreased plasma
osmolality in basal conditions, a decreased ability to excrete
a water load, and an increased urinary concentrating
response to arginin vasopressin. These physiological alter-
ations are associated with defects in the AVPR2/AQP2
signalling pathway in the collecting ducts of the kidney.
Indeed, overexpression of wild type, but not that of
catalytically inactive Inpp5k in mouse collecting duct cells
results in an increased water transport associated with
increased AVPR2 expression and cAMP response to
vasopressin, and with increased AQP2 expression and
plasma membrane localization, providing a mechanism to
explain the defects observed in Inpp5k transgenic mice.
Together, we conclude that Inpp5k as an important
regulator of the AVPR2/AQP2 signalling pathway and
water metabolism.
Inpp5k is a member of the phosphoinositide 5-
phosphatases family with catalytic activity directed towards
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 [19–21, 37]. Our North-
ern blot, RT-PCR and Western blot analyses have identified
mouse Inpp5k as a ubiquitously expressed phosphatase.
Several Inpp5k mRNA and protein molecular weight forms
have been detected in mouse tissues, as in man [19]. In the
kidney, Inpp5k mRNA is also differentially expressed along
the nephron and the collecting duct, and three molecular
forms were identified in the cortex and the medulla. This
very complex pattern of expression is probably of signif-
icant relevance and must serve specific physiological
function for the Inpp5k enzyme in the different regions of
the kidney and other tissues.
Recently, PpsBrdm1 mice with a frameshift mutation in
the Inpp5k/Pps coding sequence downstream of exon 7
have been generated [21]. The homozygous PpsBrdm1
mutation caused embryonic lethality of unknown origin.
In adult heterozygous PpsBrdm1/+ mice, a significant
increase in insulin sensitivity was observed in skeletal
muscles, and these mice were also resistant to a high fat
diet-induced obesity. By contrast, no difference was
detected between control and PpsBrdm1/+ mice for insulin
signalling in the adipose tissue and for hepatic glucose
production following insulin administration. Although our
transgenic mice expressed a high amount of catalytically
active Inpp5k in skeletal muscles, no significant difference
was found in insulin and glucose tolerance tests as
compared to control mice (data not shown). This negative
result is rather surprising, because overexpression of
Inpp5k in insulin-stimulated CHO cells was reported to
inhibit phosphoinositide 3-kinase signalling by reducing
PtdIns(3,4,5)P3 concentrations and downstream signalling
[20]. In addition, we expected to observe a frank insulin
resistance in our transgenic mice which mirrored the
increase in insulin sensitivity observed in PpsBrdm1/+ mice.
The possible reason(s) of this discrepancy between our
results and those of Takenawa are currently unknown. It
could result from the use of different Inpp5k molecular
weight forms with potentially different function and/or 5-
phosphatase activities to express Inpp5k in our transgenic
mice (42 kDa) and in CHO cells (approximately 50 kDa).
Alternatively, the expression of the catalytically active
Inpp5k protein in muscles of our transgenic mice is may
be not sufficient to reproduce the in vitro effects or to
mirror the phenotype detected in the PpsBrdm1/+ mice.
Indeed, the presence of compensatory mechanisms involv-
ing other phosphoinositide phosphatases expressed in the
muscles of our transgenic mice cannot be ruled out,
similarly to the compensation of the absence of the OCRL
protein by the 75-kDa protein [23].
AVP, AVPR2 and AQP2 are key components in the
signalling pathway involved in the control of the final urine
concentration by the principal cells lining the collecting
ducts. Under basal conditions, AQP2-containing vesicles
are maintained in the subapical region of the cells. When
the organism is exposed to a loss of free water, plasma
osmolality increases, stimulating the release of AVP by the
posterior pituitary into the circulation. In turn, AVP binds to
the AVPR2 on principal cells, leading to increased cAMP
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levels stimulating the expression of AQP2 as well as the
phosphorylation and shuttle of AQP2 from subapical
storage vesicles to the apical membrane, thereby increasing
the osmotically induced water transport. Our data demon-
strate that AVPR2, AQP2 and p-AQP2 expression is
upregulated in Inpp5k transgenic kidneys. The overexpers-
sion of these three factors in collecting duct cells would
substantiate an increase in water reabsorption and the
subsequent reduced basal osmolality and delayed ability
to excrete a water load. The fact that this phenotype results
from a primary renal deficit is confirmed by the physio-
logical response of the brain, i.e., a decreased AVP mRNA
expression secondary to lower plasma osmolality. It is
noteworthy that the AQP2 mRNA and protein expressions
are distinctly upregulated in the medullary collecting ducts
of Inpp5k transgenic mice, whereas markers of other
segments (i.e., megalin and NKCC2) are found unchanged.
Furthermore, our studies in the mCCD cells demonstrate
that Inpp5k overexpression alone, and not its catalytic
mutant, is sufficient to upregulate AVPR2, increasing the
cAMP response to dDAVP, which could then explain the
observed increase in AQP2 expression and osmotic water
transport. Unfortunately, we were unable to investigate the
effects of a decreased Inpp5k protein expression on the
AVP/AQP2 signalling pathway in this cellular system,
because of the different kinetics of AQP2 expression and
siRNA-induced Inpp5k downregulation in mCCD cells
(data not shown).
Interestingly, no proximal tubule phenotype was detected
in Inpp5k transgenic mice, despite expression of the
transgene in this nephron segment. This may be related to
the fact that the AQP1 water channels expressed in these
tubules are constitutively inserted in the plasma membrane,
without trafficking regulation nor response to AVP.
The mechanism leading to increased expression of
AVPR2 and AQP2 mRNA as well as to increased AQP2
plasma membrane localization in collecting duct cells
overexpressing Inpp5k certainly requires an intact phos-
phoinositide 5-phosphatase activity. Phosphoinositides sig-
nalling occurs in many different intracellular membranes,
including the inner surface of the plasma membrane and the
membrane vesicles that move to the plasma membrane,
providing a potential explanation for the increased AQP2
expression at the cell surface of collecting duct cells when
catalytically active Inpp5k is overexpressed. It is notewor-
thy that a still poorly defined nuclear phosphoinositide
signalling pathway, including PtdIns(4,5)P2 signalling, also
occurs and has been shown to control gene expression,
mRNA export as well as chromatin remodelling [4, 27].
The overexpression of the inositol Inpp5k 5-phosphatase in
mCCD cells represents thus a new model to understand
how phosphoinositides enter the nucleus and impact on
nuclear processes.
In conclusion, we have here for the first time identified a
role for the inositol 5-phosphatase Inpp5k in the mouse
kidney: Inpp5k controls plasma osmolality via the regula-
tion of the AVPR2/AQP-2 signalling pathway and of water
transport in kidney collecting duct cells. Although the role
of Inpp5k in the human kidney has not been investigated,
our data suggest that Inpp5k could be important in patients
with inappropriate water handling by the collecting duct.
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